Basic Information
Helix Biopharma Corp is a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology to prevent and treat cancer based on its proprietary technology platform, DOS47. DOS47 provides a novel and revolutionary approach to destroying cancer cells by modulating the tumor microenvironment.
Helix Biopharma Corp
Toronto,Ontario,Canada
less than 15 people
January 01, 1995
helix@helixbiopharma.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios